BILLS-117hr153ih.pdf

15 U.S.C. 45 2003 2021 30 days 1112 6 180-day 5-year later than 30 days JANUARY 4, 2021 9 year 15 U.S.C. 12(a later than 6 years 2009 42 U.S.C. 1-year 3-year

SESSION H. the ‘‘Protecting Consumer 2 Access to

PO 00000 Frm 00016 PO 00000 Frm 00003 Fmt PO 00000 Frm 00012 PO 00000 Frm 00007 PO 00000 Frm 00018 PO 00000 Frm PO 00000 Frm 00010 PO 00000 Frm 00009 PO 00000 Frm 00001 PO 00000 Frm 00013 PO 00000 Frm 00005 PO 00000 Frm 00006 PO 00000 Frm 00002 PO 00000 Frm 00020 PO 00000 Frm 00019 PO 00000 Frm 00015 PO 00000 Frm 00008 Fmt PO 00000 Frm 00011 Fmt PO 00000 Frm 00004 PO 00000 Frm 00017

the United States the United States Patent and Trade- the District of Columbia United States the United States of America

IH

NDA Commission U.S.C. the Federal Food, Drug SEC the Federal Trade Commission Act Food and Drugs Federal the United States Court the Federal Trade Commission the Public Health Service the Federal Trade Federal Food, Drug the Department of Justice Food, Drug FEDERAL TRADE COMMISSION RULEMAKING Biologics Congress Senate the Medicare Prescription Drug, Improvement sumer Access House of Representa- the Public Health Service Act Federal Regulations GENERAL.—If Consumer Access Medicare uct the Federal Food the Federal Trade Commis- Federal Trade Energy and Commerce THE HOUSE OF REPRESENTATIVES the Committee Committee the Food and Drug Administration

NEGUSE COHEN RUIZ VAN CASTEN SION CONNOLLY RUSH UNDERWOOD

patent generic manufacturers holder federal trade subsequent product trade commission commission act bio delay entry biosimilar drug claim